Evidence map›Paper›PMID 36425534›Full record

ReviewAmerican journal of preventive cardiology2022

Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology.

Charles A German, Seth J Baum, Keith C Ferdinand, Martha Gulati, Tamar S Polonsky, Peter P Toth, Michael D Shapiro

Open access · goldAbstract readReview
In one paragraph

Review in American journal of preventive cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Observational
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Charles A GermanSection of Cardiology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Seth J BaumDepartment of Integrated Medical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA.
Keith C FerdinandTulane Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, USA.
Martha GulatiBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Tamar S PolonskySection of Cardiology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Peter P TothCicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD and CGH Medical Center, Sterling, IL, USA.
Michael D ShapiroSection on Cardiovascular Medicine, Center for Prevention of Cardiovascular Disease, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
University of Chicago · USCedars-Sinai Medical Center · USFlorida Atlantic University · USJohns Hopkins University · USTulane University · USWake Forest University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remarkable transformations in science and healthcare have resulted in declines in mortality from cardiovascular disease over the past several decades, largely driven by progress in prevention and treatment of persons at risk. However, these trends are now beginning to stall, as our county faces increases in cardiovascular risk factors including overweight and obesity, type 2 diabetes mellitus, and metabolic syndrome. Furthermore, poor long-term adherence to a healthy lifestyle and lifesaving pharmacotherapy have exacerbated these trends, with recent data suggesting unprecedented increases in cardiovascular morbidity and mortality. A paradigm shift is needed to improve the cardiovascular health of our nation. Preventive cardiology, a growing subspecialty of cardiovascular medicine, is the practice of primordial, primary, and secondary prevention of all cardiovascular diseases. Preventive cardiologists and preventive cardiology specialists are well equipped with the knowledge and skill-set necessary to reduce deaths related to the growing burden of heart disease and its risk factors. Despite dedicated efforts, cardiovascular disease remains the leading killer of men and women in the United States. Although there is little debate regarding the importance of prevention, many healthcare professionals question the need for preventive cardiology as a distinct subspecialty. Additionally, the field's growth has been hampered by a lack of organization and standardization, and variability of training within programs across the country. The purpose of this document is to delineate the key attributes that define the field of preventive cardiology according to the American Society for Preventive Cardiology.

Indexed as

ACC, american college of cardiologyAHA, american heart associationASPC, american society for preventive cardiologyAtherosclerosisBMI, body mass indexCAC, coronary artery calciumCardiovascular diseaseCCTA, coronary CT angiographyCMS, centers for medicare and medicaid servicesCR, cardiac rehabilitationCVD, cardiovascular diseaseCVH, cardiovascular healthDHA, docosahexaenoic acidEPA, eicosapentaenoic acidFHS, framingham heart studyGLP1-RA, glucagon-like peptide 1 receptor agonistsLDL-C, low-density lipoprotein cholesterolMets, metabolic syndromeNHANES, national health and nutrition examination surveyNIH, national institutes of healthNNT, number needed to treatOSA, obstructive sleep apneaPAD, peripheral artery diseasePA, physical activityPCE, pooled cohort equationsPCSK9, proprotein convertase subtilisin kexin 9Preventive cardiologyPrimary preventionPrimordial preventionRisk assessmentSecondary preventionSES, socioeconomic statusSGLT2i, sodium glucose cotransporter 2 inhibitorsT2DM, type 2 diabetes mellitusUS, united states

Identifiers

PMID36425534
PMCPMC9679464
OpenAlexW4309341706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.